This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...
While apixaban was linked to more total major bleeds, rates of fatal and intracranial hemorrhage were similar to aspirin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results